Products for Research Use Only
RegisterLogin

Prostaglandin J2

CAT: 0804-HY-113366Size: 500 μg (14.95 mM x 100 μL in Methyl Acetate)Dry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-113366Size:500 μg (14.95 mM x 100 μL in Methyl Acetate)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Prostaglandin J2 (PGJ2), an endogenous metabolite of Prostaglandin D2 (PGD2; HY-101988), is a potent PGD2 receptor (DP) agonist with Kis of 0.9 nM and 6.6 nM for hDP and hCRTH2, respectively. Prostaglandin J2 stimulates intracellular cyclic AMP production with an EC50 value of 1.2 nM. Prostaglandin J2 induces oxidative stress and neuronal apoptosis. Prostaglandin J2 induces the accumulation/aggregation of ubiquitinated (Ub) proteins. Prostaglandin J2 is highly neurotoxic and potentially contributes to many neurodegenerative conditions, including Alzheimer's (AD) and Parkinson's diseases (PD)[2][3][4].
CAS Number
60203-57-8
Product Name Alternative
PGJ2
UNSPSC
12352211
Hazard Statement
H225, H319, H336
Target
Endogenous Metabolite; Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/prostaglandin-j2.html
Concentration
14.95 mM * 100 μL in Methyl acetate
Purity
98.10
Smiles
CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C=CC1=O)C/C=C\CCCC(O)=O
Molecular Formula
C20H30O4
Molecular Weight
334.45
Precautions
H225, H319, H336
References & Citations
[1]D H Wright, et al. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Br J Pharmacol. 1998 Apr;123 (7) :1317-24.|[2]Nicole Sawyer, et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol. 2002 Dec;137 (8) :1163-72.|[3]Maria E Figueiredo-Pereira, et al. Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration. Ann N Y Acad Sci. 2016 Jan;1363 (1) :125-37.|[4]Chuhyon Corwin, et al. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets. J Neuroinflammation. 2018 Sep 20;15 (1) :272.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DP; EP; FP; Human Endogenous Metabolite; IP; TXA2/TP

Related Products

CatalogName
HY-15648A-01GSK-J2
HY-15648IGSK-J2 (sodium)
HY-124653-01HSP27 inhibitor J2
HY-120656-01Prostaglandin K2
HY-126819Prostaglandin H1
HY-116778-01Prostaglandin G2
HY-113481-01Prostaglandin E3
HY-B0131-01Prostaglandin E1
HY-113444Prostaglandin D3
HY-114822-01Prostaglandin A3

Alternative Products

CatalogName
TBI4534-5MGProstaglandin B1, Endogenous prostaglandin
TBI4461-5MGProstaglandin A1, Endogenous prostaglandin
TBI4455-10MGProstaglandin E1, Endogenous prostaglandin
AG184Prostaglandin
TBI1358-1MGProstaglandin E2, Prostaglandin E (EP) agonist
B7005-10Prostaglandin E2
TBZ1840Prostaglandin B1
TCL-00194-01Prostaglandin G1
256337Prostaglandin F2α
287111-01Prostaglandin F2a

Popular Products